January 20, (THEWILL) – The World Anti-Doping Agency confirmed on Monday it would not pursue an appeal regarding Polish tennis star, Iga Swiatek’s one-month suspension from 2023.
The organisation stated their investigation determined the athlete’s explanation of contaminated melatonin was credible.
Swiatek, who holds five Grand Slam titles, withdrew from tennis competitions in Asia during September 2023, initially citing personal reasons.
It later emerged that the former world number one had received a suspension after testing positive for trimetazidine, a prohibited cardiac medication.
The International Tennis Integrity Agency previously accepted Swiatek’s position that the violation occurred unintentionally through contaminated over-the-counter medication.
The Polish star agreed to serve a one-month disciplinary period following the incident.
Speaking about the experience in January 2024, Swiatek described the period surrounding her suspension as “the worst time in my life,” noting the situation created significant internal distress.
Despite these challenges, she has returned to competition successfully, advancing to the Australian Open quarter-finals on Monday.
In contrast to the Swiatek decision, WADA has chosen to contest another high-profile case at the Court of Arbitration for Sport.
The organisation seeks a two-year suspension for men’s world number one Jannik Sinner, who tested positive for a prohibited steroid compound twice during March.
Sinner maintains his innocence regarding intentional substance use.
Jude Obafemi is a versatile senior Correspondent at THEWILL Newspapers, excelling in sourcing, researching, and delivering sports news stories for both print and digital publications.
